EconomyChina still has ‘catching up to do’ to become a biotech powerhouse, JPMorgan says
JPMorgan says gaps in foundational research and mounting geopolitical risks will weigh on China’s effort to build a world-class biotechnology innovation ecosystem, despite strong overseas momentum for the sector. Yang Huang, the bank’s head of China healthcare research, said China still needs to catch up in basic biological and pharmaceutical research.
China still has ‘catching up to do’ to become a biotech powerhouse, JPMorgan says
Economy